GH Research soars on planned FDA update on depression drug candidate
Tweet Send to a Friend
GH Research PLC (NASDAQ: GHRS) will provide an update on its Investigational New Drug Application status for GH001 with the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
